El proteoma del tejido adiposo subcutáneo muestra heterogeneidad anatómica

Autor: Martos-Moreno, G.A., Sackmann-Sala, L., Berryman, D.E., Blome, D.W., Argente, J., Kopchick, J.J.

Publikováno v: In Anales de Pediatria March 2013 78(3):140-148

EE138 Healthcare Resource Use (HCRU) and Associated Costs Among Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CAR-T Cells in France – A Real-World Study Using Data From PMSI

Autor: Di Blasi, R, Thieblemont, C, Haioun, C, Sackmann Sala, L, Mayaud, AC, Diez-Andreu, P, Bugnard, F, Goguillot, M, Finzi, J, Chillotti, L, Bénard, S

Publikováno v: In Value in Health December 2022 25(12) Supplement:S79-S80

Adipokine Modulation in Endometrial Hyperplasia by Polyunsaturated Fatty Acids.

Autor: Supriya, Athuru¹ (AUTHOR), Kiran, Ammu V. V. V. Ravi¹ (AUTHOR), Krishnamurthy, Praveen Thaggikuppe¹ (AUTHOR) praveentk@jssuni.edu.in

Publikováno v: Journal of Pharmacology & Pharmacotherapeutics. Sep2024, Vol. 15 Issue 3, p237-252. 16p.

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study.

Autor: Heiblig M; Hematology Department, Centre Léon Bérard, Lyon, France; INSERM U1170, Normal and Pathologic Hematopoiesis, Institut Gustave Roussy, Créteil, France., Rea D; Hematology Department, Hôpital Saint Louis, Paris, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Chrétien ML; Hematology Department, Centre Hospitalier Universitaire du Bocage, Dijon, France., Charbonnier A; Hematology Department, Institut Paoli Calmettes, Marseilles, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Rousselot P; Hematology Department, Hôpital A. Mignot, Le Chesnay, University Paris Saclay EA4340, Fontenay aux Roses, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Coiteux V; Hematology Department, Hôpital Claude Huriez, Lille, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Escoffre-Barbe M; Hematology Department, Hôpital Pontchaillou, Rennes, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Dubruille V; Hematology Department, Hotel Dieu, Nantes, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Huguet F; Hematology Department, Institut Universitaire du Cancer, Toulouse, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Cayssials E; Hematology Department, Centre Hospitalier Universitaire de Poitiers, Poitiers, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Hermet E; Hematology Department, Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Guerci-Bresler A; Hematology Department, Hôpital de Brabois, Vandoeuvre-lès-Nancy, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Amé S; Hematology Department, Hôpital Civil, Strasbourg, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Sackmann-Sala L; Incyte Biosciences France, Boulogne-Billancourt, France., Roy L; Hematology Department, Hôpital Henri Mondor, Créteil, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Sobh M; Hematology Department, Centre Léon Bérard, Lyon, France., Morisset S; Hematology Department, Centre Léon Bérard, Lyon, France., Etienne G; Hematology Department, Institut Bergonié, Bordeaux, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France., Nicolini FE; Hematology Department, Centre Léon Bérard, Lyon, France; INSERM U1052, CRCL, Lyon, France; French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France. Electronic address: franck-emmanuel.nicolini@lyon.unicancer.fr.

Publikováno v: Experimental hematology [Exp Hematol] 2018 Nov; Vol. 67, pp. 41-48. Date of Electronic Publication: 2018 Sep 05.

A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.

Autor: Sackmann Sala L; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Boutillon F; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Menara G; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., De Goyon-Pélard A; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Leprévost M; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Codzamanian J; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Lister N; Monash Partners Comprehensive Cancer Consortium and Cancer Program, Monash Biomedicine Discovery Institute, Prostate Cancer Research Group, Departments of Physiology and Anatomy and Developmental Biology, Monash University, Melbourne, Victoria, Australia., Pencik J; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Vienna, Austria., Clark A; Monash Partners Comprehensive Cancer Consortium and Cancer Program, Monash Biomedicine Discovery Institute, Prostate Cancer Research Group, Departments of Physiology and Anatomy and Developmental Biology, Monash University, Melbourne, Victoria, Australia., Cagnard N; Bioinformatics Core Facility, Inserm US 24-CNRS UMS 3633-SFR Necker, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Bole-Feysot C; Genomics Core Facility, Inserm US 24-CNRS UMS 3633-SFR Necker, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Moriggl R; Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Medical University of Vienna, Vienna, Austria., Risbridger GP; Monash Partners Comprehensive Cancer Consortium and Cancer Program, Monash Biomedicine Discovery Institute, Prostate Cancer Research Group, Departments of Physiology and Anatomy and Developmental Biology, Monash University, Melbourne, Victoria, Australia., Taylor RA; Monash Partners Comprehensive Cancer Consortium and Cancer Program, Monash Biomedicine Discovery Institute, Prostate Cancer Research Group, Departments of Physiology and Anatomy and Developmental Biology, Monash University, Melbourne, Victoria, Australia., Kenner L; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.; Department of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria., Guidotti JE; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France., Goffin V; Institut Necker Enfants Malades (INEM), Inserm U1151-CNRS UMR 8253, University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, France.

Publikováno v: The Journal of pathology [J Pathol] 2017 Sep; Vol. 243 (1), pp. 51-64. Date of Electronic Publication: 2017 Jul 28.